Please use this identifier to cite or link to this item:
http://hdl.handle.net/10362/145347| Title: | Pfizer equity report |
| Author: | Sampaio, Pedro Maria Faria de Carvalho Corrêa de |
| Advisor: | André, Rosário |
| Keywords: | Valuation Finance |
| Defense Date: | 17-Jun-2022 |
| Abstract: | The goal of thi spaper was to find the intrinsic value of Pfizer($PFE).In order to achieve this, an analysis was made of its business units and the Pharmaceutical Industry as a whole. Our valuation model, based on forecasted values, got us a share price of $69.28, which allows us to understand how fundamentally undepreciated is the current stock price. |
| URI: | http://hdl.handle.net/10362/145347 |
| Designation: | A Work Project, presented as part of the requirements for the Award of a Masters Degree in Finance from the NOVA – School of Business and Economics |
| Appears in Collections: | NSBE: Nova SBE - MA Dissertations |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| 2020-21_fall_44271_pedrosampaio.pdf | 2,05 MB | Adobe PDF | View/Open |
Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.
